CK Life Sciences International Holdings (STU:LSI) Operating Cash Flow per Share : €0.01 (TTM As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is CK Life Sciences International Holdings Operating Cash Flow per Share?

CK Life Sciences International Holdings's operating cash flow per share for the six months ended in Dec. 2023 was €0.01. CK Life Sciences International Holdings's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2023 was €0.01.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of CK Life Sciences International Holdings was 39.50% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -1.20% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 11.00% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 5.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for CK Life Sciences International Holdings's Operating Cash Flow per Share or its related term are showing as below:

STU:LSI' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -25.6 Med: 3.75 Max: 57.8
Current: -1.2

During the past 13 years, CK Life Sciences International Holdings's highest 3-Year average Operating Cash Flow per Share Growth Rate was 57.80% per year. The lowest was -25.60% per year. And the median was 3.75% per year.

STU:LSI's 3-Year OCF Growth Rate is ranked worse than
56.45% of 1233 companies
in the Biotechnology industry
Industry Median: 3.5 vs STU:LSI: -1.20

CK Life Sciences International Holdings Operating Cash Flow per Share Historical Data

The historical data trend for CK Life Sciences International Holdings's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CK Life Sciences International Holdings Operating Cash Flow per Share Chart

CK Life Sciences International Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Operating Cash Flow per Share

Get a 7-Day Free Trial

0.01

CK Life Sciences International Holdings Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Operating Cash Flow per Share	Get a 7-Day Free Trial															0.01	-	-	-	0.01

Competitive Comparison of CK Life Sciences International Holdings's Operating Cash Flow per Share

For the Biotechnology subindustry, CK Life Sciences International Holdings's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CK Life Sciences International Holdings's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CK Life Sciences International Holdings's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where CK Life Sciences International Holdings's Price-to-Operating-Cash-Flow falls into.

CK Life Sciences International Holdings Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

CK Life Sciences International Holdings's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (A: Dec. 2023 )	=	Cash Flow from Operations (A: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2023 )
	=	60.373	/	9611.073
	=	0.01

CK Life Sciences International Holdings's Operating Cash Flow per Share for the quarter that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (Q: Dec. 2023 )	=	Cash Flow from Operations (Q: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (Q: Dec. 2023 )
	=	50.922	/	9611.073
	=	0.01

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.01

CK Life Sciences International Holdings Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of CK Life Sciences International Holdings's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

CK Life Sciences International Holdings (STU:LSI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CK Life Sciences International Holdings Inc (STU:LSI) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

00775:Hong Kong

Address

2 Dai Fu Street, Tai Po Industrial Estate, Tai Po, Hong Kong, HKG

Website

https://www.ck-lifesciences.com

CK Life Sciences International Holdings Inc is a biotechnology company engaged in the research & development, commercialization, and sale of health and agricultural-related products. Products developed by CK Life Sciences are categorized into the areas of human health and environmental sustainability. The company operates three core businesses, including agriculture, nutraceutical, and pharmaceutical. Its overall product portfolio involves a presence that spans North America and the Asia Pacific. The company uses mergers and acquisitions when it identifies attractive market opportunities.